
dexamethasone intravitreal brand names and other generic formulations include:
No brand names available
emtricitabine-rilpivirine-tenofovir oral brand names and other generic formulations include:
dexamethasone intravitreal and emtricitabine-rilpivirine-tenofovir oral
dexamethasone intravitreal decreases levels of emtricitabine-rilpivirine-tenofovir oral by altering drug metabolism. Do not use together; Potential for loss of virologic response and possible resistance to rilpivirine or to the NNRTI class.
dexamethasone intravitreal and emtricitabine-rilpivirine-tenofovir oral
dexamethasone intravitreal decreases levels of emtricitabine-rilpivirine-tenofovir oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Rilpivirine should not be co-administered with strong CYP 3A4 inducers. Potential for loss of virologic response and possible resistance to rilpivirine or to the NNRTI class.
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant